Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 196

1.

SND1 affects proliferation of hepatocellular carcinoma cell line SMMC-7721 by regulating IGFBP3 expression.

Yin J, Ding J, Huang L, Tian X, Shi X, Zhi L, Song J, Zhang Y, Gao X, Yao Z, Jing X, Yang J.

Anat Rec (Hoboken). 2013 Oct;296(10):1568-75. doi: 10.1002/ar.22737. Epub 2013 Jul 22.

PMID:
23878061
[PubMed - indexed for MEDLINE]
2.

FAM9C plays an anti-apoptotic role through activation of the PI3K/Akt pathway in human hepatocellular carcinoma.

Zhou JD, Shen F, Ji JS, Zheng K, Huang M, Wu JC.

Oncol Rep. 2013 Sep;30(3):1275-84. doi: 10.3892/or.2013.2592. Epub 2013 Jul 5.

PMID:
23836295
[PubMed - indexed for MEDLINE]
3.

miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β.

Li HP, Zeng XC, Zhang B, Long JT, Zhou B, Tan GS, Zeng WX, Chen W, Yang JY.

Carcinogenesis. 2013 Nov;34(11):2443-51. doi: 10.1093/carcin/bgt206. Epub 2013 Jun 5.

PMID:
23740840
[PubMed - indexed for MEDLINE]
4.

Overexpression of HOXA1 correlates with poor prognosis in patients with hepatocellular carcinoma.

Zha TZ, Hu BS, Yu HF, Tan YF, Zhang Y, Zhang K.

Tumour Biol. 2012 Dec;33(6):2125-34. doi: 10.1007/s13277-012-0472-6. Epub 2012 Aug 4.

PMID:
22864671
[PubMed - indexed for MEDLINE]
5.

Involvement of hepatopoietin Cn in the development of human hepatocellular carcinoma.

Zhu BD, Li XL, Liu Y, Chang J, Liu Y, Zhang DD, Wang Q, Ren J, Cui CP.

Clin Exp Metastasis. 2010 Dec;27(8):571-80. doi: 10.1007/s10585-010-9346-8. Epub 2010 Aug 4.

PMID:
20683644
[PubMed - indexed for MEDLINE]
6.

shRNA-mediated silencing of Gli2 gene inhibits proliferation and sensitizes human hepatocellular carcinoma cells towards TRAIL-induced apoptosis.

Zhang D, Liu J, Wang Y, Chen J, Chen T.

J Cell Biochem. 2011 Nov;112(11):3140-50. doi: 10.1002/jcb.23240.

PMID:
21695716
[PubMed - indexed for MEDLINE]
7.

The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.

Chen YL, Uen YH, Li CF, Horng KC, Chen LR, Wu WR, Tseng HY, Huang HY, Wu LC, Shiue YL.

Ann Surg Oncol. 2013 Nov;20(12):4041-54. doi: 10.1245/s10434-012-2519-8. Epub 2012 Aug 22.

PMID:
22911364
[PubMed - indexed for MEDLINE]
8.

CYLD controls c-MYC expression through the JNK-dependent signaling pathway in hepatocellular carcinoma.

Pannem RR, Dorn C, Ahlqvist K, Bosserhoff AK, Hellerbrand C, Massoumi R.

Carcinogenesis. 2014 Feb;35(2):461-8. doi: 10.1093/carcin/bgt335. Epub 2013 Oct 8.

PMID:
24104553
[PubMed - indexed for MEDLINE]
9.

C1GALT1 enhances proliferation of hepatocellular carcinoma cells via modulating MET glycosylation and dimerization.

Wu YM, Liu CH, Huang MJ, Lai HS, Lee PH, Hu RH, Huang MC.

Cancer Res. 2013 Sep 1;73(17):5580-90. doi: 10.1158/0008-5472.CAN-13-0869. Epub 2013 Jul 5.

PMID:
23832667
[PubMed - indexed for MEDLINE]
10.

Multifunction protein staphylococcal nuclease domain containing 1 (SND1) promotes tumor angiogenesis in human hepatocellular carcinoma through novel pathway that involves nuclear factor κB and miR-221.

Santhekadur PK, Das SK, Gredler R, Chen D, Srivastava J, Robertson C, Baldwin AS Jr, Fisher PB, Sarkar D.

J Biol Chem. 2012 Apr 20;287(17):13952-8. doi: 10.1074/jbc.M111.321646. Epub 2012 Mar 6.

PMID:
22396537
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

A potential role for the homeoprotein Hhex in hepatocellular carcinoma progression.

Su J, You P, Zhao JP, Zhang SL, Song SH, Fu ZR, Ye LW, Zi XY, Xie DF, Zhu MH, Hu YP.

Med Oncol. 2012 Jun;29(2):1059-67. doi: 10.1007/s12032-011-9989-6. Epub 2011 Jun 8.

PMID:
21656028
[PubMed - indexed for MEDLINE]
12.

The insulin-like growth factor-1 and expression of its binding protein‑3 in chronic hepatitis C and hepatocellular carcinoma.

Adamek A, Kasprzak A, Mikoś H, Przybyszewska W, Seraszek-Jaros A, Czajka A, Sterzyńska K, Mozer-Lisewska I.

Oncol Rep. 2013 Sep;30(3):1337-45. doi: 10.3892/or.2013.2546. Epub 2013 Jun 19.

PMID:
23784592
[PubMed - indexed for MEDLINE]
13.

Enhanced production of CTGF and IL-11 from highly metastatic hepatoma cells under hypoxic conditions: an implication of hepatocellular carcinoma metastasis to bone.

Gao YB, Xiang ZL, Zhou LY, Wu ZF, Fan J, Zeng HY, Zeng ZC.

J Cancer Res Clin Oncol. 2013 Apr;139(4):669-79. doi: 10.1007/s00432-012-1370-4. Epub 2013 Jan 10.

PMID:
23307318
[PubMed - indexed for MEDLINE]
14.

Survivin-mediated cancer cell migration through GRP78 and epithelial-mesenchymal transition (EMT) marker expression in Mahlavu cells.

Tai CJ, Chin-Sheng H, Kuo LJ, Wei PL, Lu HH, Chen HA, Liu TZ, Liu JJ, Liu DZ, Ho YS, Wu CH, Chang YJ.

Ann Surg Oncol. 2012 Jan;19(1):336-43. doi: 10.1245/s10434-011-1692-5. Epub 2011 Apr 23.

PMID:
21516372
[PubMed - indexed for MEDLINE]
15.

Downregulation of NIN/RPN12 binding protein inhibit the growth of human hepatocellular carcinoma cells.

Lu Z, Guo Q, Shi A, Xie F, Lu Q.

Mol Biol Rep. 2012 Jan;39(1):501-7. doi: 10.1007/s11033-011-0764-8. Epub 2011 May 15.

PMID:
21573803
[PubMed - indexed for MEDLINE]
16.

Lentiviral-mediated Smad4 RNAi induced anti-proliferation by p16 up-regulation and apoptosis by caspase 3 down-regulation in hepatoma SMMC-7721 cells.

Huang S, Zhang F, Miao L, Zhang H, Fan Z, Wang X, Ji G.

Oncol Rep. 2008 Nov;20(5):1053-9.

PMID:
18949401
[PubMed - indexed for MEDLINE]
17.

Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma.

Kim JK, Jung KH, Noh JH, Eun JW, Bae HJ, Xie HJ, Ahn YM, Ryu JC, Park WS, Lee JY, Nam SW.

Int J Oncol. 2009 Dec;35(6):1257-64.

PMID:
19885547
[PubMed - indexed for MEDLINE]
18.

High expression of insulin-like growth factor binding protein-3 is correlated with lower portal invasion and better prognosis in human hepatocellular carcinoma.

Aishima S, Basaki Y, Oda Y, Kuroda Y, Nishihara Y, Taguchi K, Taketomi A, Maehara Y, Hosoi F, Maruyama Y, Fotovati A, Oie S, Ono M, Ueno T, Sata M, Yano H, Kojiro M, Kuwano M, Tsuneyoshi M.

Cancer Sci. 2006 Nov;97(11):1182-90. Epub 2006 Sep 12.

PMID:
16965600
[PubMed - indexed for MEDLINE]
19.

[Inhibition of SMYD3 gene expression by RNA interference induces apoptosis in human hepatocellular carcinoma cell line HepG2].

Xu JY, Chen LB, Xu JY, Yang Z, Wei HY, Xu RH.

Ai Zheng. 2006 May;25(5):526-32. Chinese.

PMID:
16687068
[PubMed - indexed for MEDLINE]
20.

Androgen activates PEG10 to promote carcinogenesis in hepatic cancer cells.

Jie X, Lang C, Jian Q, Chaoqun L, Dehua Y, Yi S, Yanping J, Luokun X, Qiuping Z, Hui W, Feili G, Boquan J, Youxin J, Jinquan T.

Oncogene. 2007 Aug 23;26(39):5741-51. Epub 2007 Mar 19. Retraction in: Oncogene. 2011 Jun 16;30(24):2798.

PMID:
17369855
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk